EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Artificial Intelligence in Valvular Heart Disease

Annette Maznyczka, Rutger-Jan Nuis, Isaac Shiri, Julien Ternacle, Philippe Garot, Mark M P van den Dorpel, Arif A Khokhar, Raffaele De Lucia, Michele Orini, Shelby Kutty, Julia Grapsa, Christoph Gräni und 16 weitere

JACC: Cardiovascular Interventions · 2025

DOI: 10.1016/j.jcin.2025.08.031 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JACC: Cardiovascular Interventions, 2025. Verfasst von Annette Maznyczka und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom. Electronic address: https://twitter.com/AMaznyczka. Hauptthemen laut MEDLINE: Heart Valve Diseases, Artificial Intelligence, Heart Valves, Decision Support Techniques. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Managing valvular heart disease (VHD) requires integrating multimodal data, including demographics, symptoms, biomarkers, electrocardiogram findings, and imaging studies. However, the capacity and processing power of the human mind are limited, particularly in the current era where vast quantities of complex data require rapid processing. Integrating artificial intelligence (AI) into the management of VHD offers an opportunity to enhance diagnostic accuracy, streamline clinical workflows, optimize procedural strategies, and predict outcomes and disease progression. Subsets of AI such as machine learning and deep learning algorithms can uncover the unseen data from routine investigations (eg, electrocardiograms, echocardiography, and computed tomography), providing robust and accurate risk prediction tools to inform personalized treatment strategies. Intraprocedurally, AI-based enhancements in imaging guidance can be leveraged to improve procedural safety and success. Digital twin technology can allow case-specific disease modelling, such as simulating valve designs and predicting adverse events, fostering precision medicine. By using the full potential of AI, clinicians can provide a comprehensive, personalized management strategy for VHD patients, ultimately enhancing clinical outcomes. However, models based on AI algorithms require rigorous validation across multiple centers to ensure their reliability. Concerns about bias, data privacy, and limited transparency challenge the application of AI decision-making to digital health care. This review discusses the applications of AI in the management of patients with VHD, highlights the future directions of AI technologies, and considers the challenges of integrating AI into clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve DiseasesArtificial IntelligenceHeart ValvesDecision Support TechniquesImage Interpretation, Computer-AssistedHumansPredictive Value of TestsDiffusion of InnovationClinical Decision-MakingForecastingPrecision MedicineRisk AssessmentRisk FactorsTreatment OutcomePrognosis

Stichwörter der Autor:innen

artificial intelligencedigital twinfusion imagingmulti-modality imagingvalvular heart disease

Autor:innen und Institutionen

  • Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom. Electronic address: https://twitter.com/AMaznyczka.
  • Department of Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
  • Haut-Leveque Cardiology Hospital, CHU Bordeaux, Pessac, France; Cardio-Thoracic Research Centre, University of Bordeaux, Bordeaux, France.
  • Institut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France. Electronic address: https://twitter.com/DrGarot.
  • Department of Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: https://twitter.com/markvddorpel.

Zitieren

APA

Maznyczka, A., Nuis, R. J., Shiri, I., Ternacle, J., Garot, P., van den Dorpel, M. M. P., Khokhar, A. A., De Lucia, R., Orini, M., Kutty, S., Grapsa, J., Gräni, C., Pandey, A., Becker, T., O'Gallagher, K., Mortier, P., Dasi, L. P., Kofoed, K. F., Engelhardt, S., …, & De Backer, O. (2025). Artificial Intelligence in Valvular Heart Disease. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2025.08.031

Vancouver

Maznyczka A, Nuis RJ, Shiri I, Ternacle J, Garot P, van den Dorpel MMP, et al. Artificial Intelligence in Valvular Heart Disease. JACC: Cardiovascular Interventions. 2025. doi:10.1016/j.jcin.2025.08.031

BibTeX
@article{Maznyczka2025,
  author = {Maznyczka, Annette and Nuis, Rutger-Jan and Shiri, Isaac and Ternacle, Julien and Garot, Philippe and van den Dorpel, Mark M P and Khokhar, Arif A and De Lucia, Raffaele and Orini, Michele and Kutty, Shelby and Grapsa, Julia and Gräni, Christoph and Pandey, Ambarish and Becker, Taylor and O'Gallagher, Kevin and Mortier, Peter and Dasi, Lakshmi Prasad and Kofoed, Klaus Fuglsang and Engelhardt, Sandy and Biaggi, Patric and Ahmad, Faraz S and Wang, Dee Dee and Leroux, Lionel and Modine, Thomas and Windecker, Stephan and Hahn, Rebecca T and Van Mieghem, Nicolas M and De Backer, Ole},
  title = {Artificial Intelligence in Valvular Heart Disease},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1016/j.jcin.2025.08.031}
}
Kostenlos starten →